Tuberculosis in Africa: clinical presentation and management

Area of Science:

• Public Health
• Infectious Diseases
• Epidemiology

Background:

• Sub-Saharan Africa has seen a significant rise in tuberculosis (TB) cases.
• This increase is strongly linked to the co-epidemic of human immunodeficiency virus (HIV) infection.
• The region faces unique epidemiological challenges in managing these intertwined diseases.

Purpose of the Study:

• To review the epidemiology of TB in sub-Saharan Africa.
• To discuss clinical features, diagnostic challenges, and treatment of TB in adults and children, especially concerning HIV.
• To examine TB control strategies and prevention methods in the African context.

Main Methods:

• Review of existing literature on TB and HIV epidemiology in sub-Saharan Africa.
• Analysis of clinical presentations and diagnostic difficulties associated with TB/HIV co-infection.
• Evaluation of various TB treatment regimens, including cost, adverse effects, and drug resistance patterns.
• Examination of preventive strategies like Bacillus Calmette-Guerin (BCG) vaccination and chemoprophylaxis.
• Assessment of National TB Control Programmes' effectiveness.

Main Results:

• HIV infection significantly impacts TB clinical presentation, diagnosis, and treatment response.
• Drug resistance is a growing concern in TB management within the region.
• Varied treatment outcomes are observed, influenced by factors like cost, adverse reactions, and HIV status.
• Preventive measures and robust National TB Control Programmes show promise.

Conclusions:

• The TB/HIV co-epidemic in sub-Saharan Africa requires integrated management strategies.
• Addressing diagnostic challenges and drug resistance is crucial for effective TB control.
• Successful National TB Control Programmes demonstrate that the epidemic can be controlled with sustained effort and resources.